Argent Capital Management LLC decreased its position in Danaher Co. (NYSE:DHR – Free Report) by 2.5% during the 4th quarter, Holdings Channel reports. The firm owned 377,991 shares of the conglomerate’s stock after selling 9,559 shares during the quarter. Danaher comprises about 2.4% of Argent Capital Management LLC’s holdings, making the stock its 14th biggest position. Argent Capital Management LLC’s holdings in Danaher were worth $86,768,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the company. Teachers Insurance & Annuity Association of America purchased a new position in Danaher during the third quarter worth about $39,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Danaher in the third quarter valued at about $40,000. FSA Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at about $50,000. Darwin Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at about $55,000. Finally, Dunhill Financial LLC grew its stake in Danaher by 45.1% during the 3rd quarter. Dunhill Financial LLC now owns 222 shares of the conglomerate’s stock valued at $62,000 after purchasing an additional 69 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently commented on DHR. Scotiabank began coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Robert W. Baird cut their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. KeyCorp lifted their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. TD Cowen lifted their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Finally, Stifel Nicolaus lifted their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $286.80.
Danaher Price Performance
Shares of NYSE DHR opened at $237.78 on Thursday. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The stock has a market capitalization of $171.74 billion, a price-to-earnings ratio of 45.38, a PEG ratio of 4.23 and a beta of 0.83. The business has a 50-day moving average of $235.27 and a 200-day moving average of $253.56. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the business posted $2.02 earnings per share. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, sell-side analysts predict that Danaher Co. will post 7.49 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher’s dividend payout ratio (DPR) is 20.61%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- How to invest in marijuana stocks in 7 stepsĀ
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- What is an Earnings Surprise?
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
- What Are Growth Stocks and Investing in Them
- D-Wave’s Stock Springs Back in the Quantum Computing Race
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.